Understand the source comparison
SS-31 Quality: Real Peptides vs Competitors | 2026 Analysis
A 2023 analysis published in Analytical Biochemistry found that nearly 40% of research-grade peptides tested from third-party suppliers failed to meet labeled purity specifications when verified by independent HPLC. And SS-31 (elamipretide), a mitochondrial-ta
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- A 2023 analysis published in Analytical Biochemistry found that nearly 40% of research-grade peptides tested from third-party suppliers failed to meet labeled purity specifications when verified by independent HPLC. And SS-31 (elamipretide), a mitochondrial-targeting antioxidant peptide, was among the compounds with the highest variability. The issue isn't just contamination. It's structural degradation during synthesis, improper lyophilization, and temperature excursions during shipping that render the peptide sequence intact on paper but functionally compromised in practice.
- Our team has guided research institutions through peptide sourcing for mitochondrial biology studies across three continents. The difference between suppliers who understand peptide stability and those who treat SS-31 like a commodity chemical comes down to three things most spec sheets never mention: synthesis method documentation, third-party verification beyond CoA claims, and cold-chain integrity from batch release to lab delivery.
- What determines SS-31 peptide quality across research suppliers?
- SS-31 quality is defined by three measurable factors: synthesis purity (≥98% by HPLC with less than 2% deletion sequences), structural integrity post-lyophilization (confirmed by mass spectrometry showing correct molecular weight of 640.2 Da), and bioactivity retention through storage and reconstitution. Lower-tier suppliers often provide HPLC purity data without verifying that the peptide retains its mitochondrial membrane-targeting function. The aromatic-cationic motif that allows SS-31 to cross lipid bilayers and scavenge reactive oxygen species at Complex I. A peptide can test 99% pure by mass and still fail to localize to mitochondria if racemization occurred during coupling or if the tyrosine residue oxidized during storage.
- Here's what separates functional SS-31 from peptide waste: synthesis method matters more than purity percentage alone. Fmoc solid-phase peptide synthesis (SPPS) is the standard for short sequences like SS-31 (four amino acids: D-Arg-Dmt-Lys-Phe-NH2), but the coupling efficiency at each step and the cleavage protocol determine whether you get a single clean product or a mixture of deletion sequences and racemized analogs. Real Peptides uses small-batch SPPS with individual amino acid verification at each coupling step. Not automated large-batch synthesis where a single coupling failure propagates through the entire run. The difference shows up in side-product profiles: high-quality SS-31 has undetectable levels of des-Arg or des-Phe analogs, while cost-optimized batches from bulk suppliers routinely contain 3–8% truncated sequences that compete for mitochondrial binding sites without delivering antioxidant activity.